A subcutaneous formulation was authorized in December 2017 and an oral tablet in September 2019 for glycemic management in type 2 diabetes
GLP-1 medications are physician-prescribed treatments that help regulate appetite, blood sugar, and metabolism
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, an absorption enhancer for Ozempic and Rybelsus tablets, and because there are alternative formulations of semaglutide that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with Ozempic or Rybelsus tablets Please click here for Ozempic and Rybelsus tablets Prescribing Information, including Boxed Warning
The recommended Ozempic titration schedule starts at 0.25 mg weekly for 4 weeks, then 0.5 mg for at least 4 weeks, before reaching the 1 mg maintenance dose [5]
Lastly, if you have ever had a severe allergic reaction to a medication, it may be helpful to carry an epinephrine injector (EpiPen) in case of emergencies
These treatments are most effective with continued use
